Evolution of QC and QA in pharmaceutical industries MCQs With Answer

Introduction: This quiz collection explores the evolution of Quality Control (QC) and Quality Assurance (QA) in the pharmaceutical industry, tailored for M.Pharm students. It reviews historical milestones, regulatory drivers, and modern quality paradigms such as Good Manufacturing Practices (GMP), Quality by Design (QbD), Process Analytical Technology (PAT), and risk-based approaches. Questions emphasize how regulatory frameworks (ICH, WHO, FDA), pharmacopoeial harmonization, and technological advances shaped QC/QA roles, laboratory practices, validation, and release decisions. The set is designed to deepen conceptual understanding, test application of regulatory principles, and prepare students for professional responsibilities in contemporary pharmaceutical quality systems.

Q1. Which development most directly marked the shift from product testing to systemic quality assurance in the pharmaceutical industry?

• Adoption of organoleptic inspection as the primary release test
• Introduction of Good Manufacturing Practices (GMP) into national regulations
• Widespread use of paper batch records
• Increase in number of pharmacopoeial monographs

Correct Answer: Introduction of Good Manufacturing Practices (GMP) into national regulations

Q2. Which regulatory incident during the mid-20th century most strongly accelerated formal QC/QA reforms worldwide?

• The discovery of penicillin instability
• The thalidomide birth defect crisis
• The influenza vaccine contamination episodes
• The development of controlled-release formulations

Correct Answer: The thalidomide birth defect crisis

Q3. Quality by Design (QbD) primarily emphasizes which of the following principles?

• End-product testing as the only assurance of quality
• Understanding processes and designing control strategies based on risk
• Maximizing manual laboratory interventions
• Keeping formulation variables constant without process characterization

Correct Answer: Understanding processes and designing control strategies based on risk

Q4. Process Analytical Technology (PAT) contributes to QC/QA evolution by enabling:

• Only offline microbiological testing
• Real-time monitoring and control of critical process parameters
• Replacement of all laboratory personnel with automation
• Elimination of regulatory oversight

Correct Answer: Real-time monitoring and control of critical process parameters

Q5. Which ICH guideline introduced the concept of pharmaceutical quality risk management that influenced QA systems?

• ICH Q1A (Stability)
• ICH Q9 (Quality Risk Management)
• ICH Q3A (Impurities)
• ICH Q7 (GMP for APIs)

Correct Answer: ICH Q9 (Quality Risk Management)

Q6. In the historical evolution of QC, the role of the QC laboratory changed from simple testing to:

• Issuing marketing approvals
• Being integral to investigational activities like OOS investigations and stability evaluation
• Designing organizational marketing campaigns
• Conducting only physical appearance checks

Correct Answer: Being integral to investigational activities like OOS investigations and stability evaluation

Q7. Current Good Manufacturing Practices (cGMP) differ from earlier GMP iterations mainly because:

• They relax documentation requirements
• They incorporate continual improvement and current state-of-the-art methods
• They mandate organoleptic testing for all products
• They remove responsibility from Quality Unit(s)

Correct Answer: They incorporate continual improvement and current state-of-the-art methods

Q8. Which document describes electronic records and signatures requirements that impacted QA for computerized systems?

• ICH Q8
• 21 CFR Part 11
• EU GMP Annex 1
• WHO Technical Report Series

Correct Answer: 21 CFR Part 11

Q9. During the maturation of QA, the function of CAPA (Corrective and Preventive Action) became central because it:

• Focuses only on preventing theft
• Provides a structured way to investigate root causes and prevent recurrence
• Replaces all batch release testing
• Only documents supplier complaints without action

Correct Answer: Provides a structured way to investigate root causes and prevent recurrence

Q10. Which of the following best describes the relationship between QC and QA in modern pharmaceutical quality systems?

• QC and QA are identical and interchangeable terms
• QC performs testing; QA oversees the quality system, including policies, audits, and approvals
• QA only conducts laboratory assays while QC writes SOPs
• QC eliminates the need for QA if sufficient testing is done

Correct Answer: QC performs testing; QA oversees the quality system, including policies, audits, and approvals

Q11. The shift toward risk-based regulatory inspections influenced QA by promoting:

• Uniform inspection of every minor activity
• Prioritization of critical processes and data integrity based on risk assessments
• Elimination of supplier qualification
• Random removal of documentation requirements

Correct Answer: Prioritization of critical processes and data integrity based on risk assessments

Q12. Harmonization efforts between major pharmacopoeias (e.g., USP, EP, JP) affected QC evolution by:

• Creating inconsistent test methods across regions
• Facilitating global standardization of analytical methods and specifications
• Eliminating the need for stability testing
• Restricting adoption of modern analytical technologies

Correct Answer: Facilitating global standardization of analytical methods and specifications

Q13. Which activity is a primary responsibility of QA during batch release?

• Performing the potency assay
• Reviewing batch documentation and approving release based on compliance with specifications and GMP
• Packaging the product
• Transporting samples to the lab

Correct Answer: Reviewing batch documentation and approving release based on compliance with specifications and GMP

Q14. The concept of continuous process verification (CPV) as part of lifecycle management is most closely associated with which regulatory guidance?

• ICH Q10 (Pharmaceutical Quality System)
• ICH Q5C (Stability of Biotechnological Products)
• ICH Q8(R2) and ICH Q11 concepts within ICH guidance on pharmaceutical development and lifecycle
• 21 CFR Part 820 (Medical Devices)

Correct Answer: ICH Q8(R2) and ICH Q11 concepts within ICH guidance on pharmaceutical development and lifecycle

Q15. In the historical context, what role did pharmacopoeias play in QC evolution?

• They replaced all regulatory oversight
• Provided standardized monographs and test procedures that formed the backbone of QC specifications
• Discouraged analytical method development
• Primarily focused on marketing guidelines

Correct Answer: Provided standardized monographs and test procedures that formed the backbone of QC specifications

Q16. An Out-of-Specification (OOS) result investigation in modern QA should begin with which principle?

• Assuming the analyst is at fault without investigation
• A scientifically guided root cause analysis considering laboratory, process, and sampling factors
• Automatically rejecting the entire production lot without review
• Delaying investigation until multiple lots fail

Correct Answer: A scientifically guided root cause analysis considering laboratory, process, and sampling factors

Q17. The rise of global supply chains changed QA/QC expectations by increasing emphasis on:

• Local-only supplier testing without audits
• Supplier qualification, audits, material traceability, and quality agreements
• Outsourcing all quality responsibilities to third parties without oversight
• Eliminating incoming materials testing

Correct Answer: Supplier qualification, audits, material traceability, and quality agreements

Q18. Stability testing evolution influenced QA by requiring companies to:

• Rely solely on accelerated data for all shelf-life claims
• Establish formal stability protocols, real-time stability data, and committed retest/expiry assignments
• Avoid ICH stability guidelines
• Assign arbitrary expiration dates without data

Correct Answer: Establish formal stability protocols, real-time stability data, and committed retest/expiry assignments

Q19. The implementation of an effective pharmaceutical quality system (as in ICH Q10) requires which core element?

• Only investments in manufacturing equipment
• Continual improvement, knowledge management, and effective defect prevention mechanisms
• Removal of management responsibility for quality
• Exclusive reliance on third-party audits with no internal oversight

Correct Answer: Continual improvement, knowledge management, and effective defect prevention mechanisms

Q20. Data integrity became a central QA concern historically because compromised data can:

• Only affect marketing strategies
• Undermine product safety and efficacy decisions, regulatory compliance, and patient trust
• Improve speed of batch release without consequences
• Be ignored if documentation is voluminous

Correct Answer: Undermine product safety and efficacy decisions, regulatory compliance, and patient trust

Download